Vaccination against dengue starts next Monday (06/05), in the afternoon

#Vaccination #dengue #starts #Monday #afternoon

The City of Bragança Paulista, through the Department of Health, received doses of vaccines against dengue on Friday afternoon (03/05). The vaccine is intended for children aged 10 to 14 years, 11 months and 29 days, the population that accounts for the highest proportion of hospitalizations. Starting next Monday (06/05), in the afternoon, the target audience can look for the Águas Claras, Centro de Saúde, Planejada 2, Vila Davi, Santa Luzia and Vila Aparecida units.

It is important to reinforce that parents or guardians MUST PRESENT the children’s vaccination card, proof of address and document with photo of the child/adolescent.

The dengue vaccine (attenuated) is an injectable solution, composed of serotypes 1, 2, 3 and 4 of the attenuated dengue virus, with the aim of reducing hospitalizations and deaths resulting from virus infections. The vaccination schedule is two doses, with a three-month interval between doses. The goal is to reach 90% of children and adolescents for the complete scheme.

Comments

After infection with the dengue virus, it is recommended to wait six months to start the vaccination schedule. In situations where infection occurs after the start of vaccination, there is no need to change the interval between dose 1 and dose 2, as long as dose 2 is not applied less than 30 days after the onset of the disease. This interval does not harm the immunological response to complete the vaccination schedule, and there is no need to restart it.

Contraindications

– Anaphylaxis to the active substance or any excipient listed in the vaccine composition section or to a previous dose of that vaccine;

– People with congenital or acquired immunodeficiency, including those receiving chemotherapy or systemic corticosteroids in high doses (for example 20 mg/day or 2 mg/kg/day of prednisone for two weeks or more), within four weeks prior to vaccination;

– People with symptomatic HIV infection or with asymptomatic HIV infection with compromised immune function;

– Pregnant women;

– Breastfeeding women (lactating women).